3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Tumor-Agnostic
1
Other solid neoplasm
1
Other neoplasm
1
Other hematologic neoplasm
1
Breast
1
Conditions
Hospice
1
Interventions
fludarabine
5
Educational Status
5
fludarabine phosphate
4
Whole-Body Irradiation
4
Mycophenolic Acid
4
Methods
4
Melphalan
4
Magnetic Resonance Spectroscopy
4
Early Intervention, Educational
4
Cyclophosphamide
4
Busulfan
4
Biopsy
4
Taxes
3
Tacrolimus
3
Specimen Handling
3
Peripheral Blood Stem Cell Transplantation
3
Paclitaxel
3
Interviews as Topic
3
venetoclax
2
Sirolimus
2
Patient Reported Outcome Measures
2
Nivolumab
2
Mesna
2
Health Promotion
2
Colposcopy
2
Cisplatin
2
Aminolevulinic Acid
2
Albumin-Bound Paclitaxel
2
toripalimab
1
tirbanibulin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Psychotherapy
×
Other neoplasm
×
1 year
×
Clear all
NCT04950608
2026-02-17
PATH
Dana-Farber Cancer Institute
Phase 2
Completed
15 enrolled
26 charts